br CRediT authorship contribution statement br

CRediT authorship contribution statement
Yusheng Lu: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing. Shu Lian: Data curation, Formal analysis, Methodology, Software. Yunlong Cheng: Data curation, Formal analysis, Methodology, Software. Yuying Ye: Formal analysis, Investigation, Methodology, Software. Xiaodong Xie: Formal analysis, Methodology. Chengbin Fu: Formal analysis, Methodology. Chen Zhang: Formal analysis. Yewei Zhu: Formal analysis, Methodology. M. Iqbal Parker: Validation, Writing - review
& editing. Lee Jia: Conceptualization, Data curation, Funding acquisition, Project administration, Resources, Supervision, Validation, Writing - review & editing.
Acknowledgments
This research was supported by the National Natural Science Foundation of China (NSFC, grant numbers 81703555, U1505225 and 81773063), the Ministry of Science and Technology of the People's Republic of China (grant number 2015CB931804); the China Postdoctoral Science Foundation (grant number 2017M620268), and the Strait Postdoctoral Exchange Grant Program of Fujian Province (grant number 02510515).
Conflicts of Interest
No potential conflicts of interest were disclosed.
References
L. Jia, Nitric oxide inhibits hetero-adhesion of cancer LY 294002 to endothelial cells: re-straining circulating tumor cells from initiating metastatic cascade, Sci. Rep. 4 (2014) 4344. [27] D. Lauri, L. Needham, I. Martin-Padura, E. Dejana, Tumor cell adhesion to en-dothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells, J. Natl. Cancer Inst. 83 (1991) 1321–1324.
L. Jia, S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells, Pharmacol. Res. (2018). [35] J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick,
J. Xie, L. Jia, Metastatic cancer cells compensate for low energy supplies in hostile microenvironments with bioenergetic adaptation and metabolic reprogramming, Int. J. Oncol. 53 (2018) 2590–2604.
Revista de Senología y Patología Mamaria
www.elsevier.es/senologia
ORIGINAL
Cirugía oncoplástica y radioterapia intraoperatoria en el cáncer de mama
Ernesto Hernando a,∗, María Carmen Casamayor a, Reyes Ibánez˜ b, Ana Palomares a, Virginia Rodrigo a, Silvia Cruz c, María Carmen García Mur c, José Ramón Oliver a y Miguel Ángel Dobón a
a Unidad de Mama, Cirugía Endocrina y Bariátrica, Servicio de Cirugía General, Hospital Universitario Miguel Servet, Zaragoza, Espana˜
b Servicio de Oncología Radioterápica, Hospital Universitario Miguel Servet, Zaragoza, Espana˜ c Servicio de Radiología, Hospital Universitario Miguel Servet, Zaragoza, Espana˜
PALABRAS CLAVE
Resumen
Cáncer de mama
Objetivo: Estudio prospectivo de pacientes con cáncer de mama precoz tratadas con ciru-
precoz;
gía conservadora oncoplástica y radioterapia intraoperatoria con intención de dosis única o
Radioterapia
monoterapia.
intraoperatoria;
Material y método: Veintitrés pacientes intervenidas entre junio de 2016 y agosto de 2018,
Cirugía oncoplástica
que han cumplido criterios de administración de radioterapia intraoperatoria establecidos por
nuestro comité multidisciplinar de tumores de mama (carcinoma ductal infiltrante < 3 cm, uni-
focal, con axila clínica y radiológicamente negativa, receptores hormonales positivos y HER2
negativo) y han sido candidatas a cirugía oncoplástica.
Resultados: Tras el estudio anatomopatológico, todas las piezas de resección tenían márgenes